NCT05697159View on ClinicalTrials.gov

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 22, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions
Rheumatoid ArthritisSickness BehaviorInflammatory DiseaseAutoimmunePain, Chronic
Trial Locations (1)

Unknown

RECRUITING

Neil Basu, Glasgow

Sponsors

Collaborators (1)

Galapagos NV
All Listed Sponsors
collaborator

Galapagos NV

INDUSTRY

lead

NHS Greater Glasgow and Clyde

OTHER

NCT05697159 - 7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter